Works by Zent, Clive S.
Results: 81
Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma Population.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e260, doi. 10.1016/j.clml.2023.05.010
- By:
- Publication type:
- Article
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relationship between megakaryocyte mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura.
- Published in:
- British Journal of Haematology, 1999, v. 105, n. 2, p. 452, doi. 10.1111/j.1365-2141.1999.01351.x
- By:
- Publication type:
- Article
Antibody‐mediated phagocytosis in cancer immunotherapy.
- Published in:
- Immunological Reviews, 2023, v. 319, n. 1, p. 128, doi. 10.1111/imr.13265
- By:
- Publication type:
- Article
Age at Diagnosis and the Utility of Prognostic Testing in Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 20, p. 4777, doi. 10.1002/cncr.25292
- By:
- Publication type:
- Article
The Treatment of Recurrent/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) With Everolimus Results in Clinical Responses and Mobilization of CLL Cells Into the Circulation.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2201, doi. 10.1002/cncr.25005
- By:
- Publication type:
- Article
Pentostatin and Rituximab Therapy for Previously Untreated Patients With B-Cell Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2180, doi. 10.1002/cncr.25028
- By:
- Publication type:
- Article
Validation of a New Prognostic Index for Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 2, p. 363, doi. 10.1002/cncr.24004
- By:
- Publication type:
- Article
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Pentostatin, Cyclophosphamide, and Rituximab Regimen in Older Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 11, p. 2291, doi. 10.1002/cncr.22662
- By:
- Publication type:
- Article
What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 6, p. 835, doi. 10.1111/bjh.14211
- By:
- Publication type:
- Article
Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 3, p. 326, doi. 10.1111/bjh.12534
- By:
- Publication type:
- Article
Diffuse large B-cell lymphoma ( Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 6, p. 774, doi. 10.1111/bjh.12458
- By:
- Publication type:
- Article
Association of an increased frequency of CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL).
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 5, p. 674, doi. 10.1111/j.1365-2141.2011.08902.x
- By:
- Publication type:
- Article
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 1, p. 53, doi. 10.1111/j.1365-2141.2011.08794.x
- By:
- Publication type:
- Article
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 4, p. 544, doi. 10.1111/j.1365-2141.2009.07982.x
- By:
- Publication type:
- Article
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 4, p. 471, doi. 10.1111/j.1365-2141.2009.07868.x
- By:
- Publication type:
- Article
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 6, p. 660, doi. 10.1111/j.1365-2141.2009.07811.x
- By:
- Publication type:
- Article
Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 5, p. 607, doi. 10.1111/j.1365-2141.2008.07070.x
- By:
- Publication type:
- Article
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 5, p. 615, doi. 10.1111/j.1365-2141.2008.07086.x
- By:
- Publication type:
- Article
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
- Published in:
- British Journal of Haematology, 2008, v. 140, n. 5, p. 537, doi. 10.1111/j.1365-2141.2007.06965.x
- By:
- Publication type:
- Article
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 3, p. 398, doi. 10.1111/j.1365-2141.2007.06801.x
- By:
- Publication type:
- Article
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 2, p. 255, doi. 10.1111/j.1365-2141.2007.06791.x
- By:
- Publication type:
- Article
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 13, p. 2000, doi. 10.1002/cncr.28690
- By:
- Publication type:
- Article
Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL).
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 21, p. 3788, doi. 10.1002/cncr.28292
- By:
- Publication type:
- Article
Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 2, p. 363, doi. 10.1002/cncr.27719
- By:
- Publication type:
- Article
Hematologist/oncologist disease-specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 7, p. 1827, doi. 10.1002/cncr.26474
- By:
- Publication type:
- Article
Maxed out macs: physiologic cell clearance as a function of macrophage phagocytic capacity.
- Published in:
- FEBS Journal, 2017, v. 284, n. 7, p. 1021, doi. 10.1111/febs.13961
- By:
- Publication type:
- Article
Complement Activation in the Treatment of B-Cell Malignancies.
- Published in:
- Antibodies (2073-4468), 2020, v. 9, n. 4, p. 68, doi. 10.3390/antib9040068
- By:
- Publication type:
- Article
Narrative Review: Initial Management of Newly Diagnosed, Early-Stage Chronic Lymphocytic Leukemia.
- Published in:
- Annals of Internal Medicine, 2006, v. 145, n. 6, p. 435, doi. 10.7326/0003-4819-145-6-200609190-00007
- By:
- Publication type:
- Article
Initial treatment of B‐cell prolymphocytic leukemia with ibrutinib.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. E108, doi. 10.1002/ajh.25733
- By:
- Publication type:
- Article
Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E16, doi. 10.1002/ajh.25663
- By:
- Publication type:
- Article
Ibrutinib therapy for lymphoplasmacytic lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E542, doi. 10.1002/ajh.24795
- By:
- Publication type:
- Article
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 308, doi. 10.1002/ajh.24265
- By:
- Publication type:
- Article
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 757, doi. 10.1002/ajh.23737
- By:
- Publication type:
- Article
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
- By:
- Publication type:
- Article
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 9, p. 880, doi. 10.1002/ajh.23273
- By:
- Publication type:
- Article
mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD).
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 8, p. 688, doi. 10.1002/ajh.21216
- By:
- Publication type:
- Article
Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Published in:
- American Journal of Hematology, 2001, v. 68, n. 4, p. 287, doi. 10.1002/ajh.10006
- By:
- Publication type:
- Article
Persistent polyclonal B‐cell lymphocytosis: Illustration of the great mimicker of low‐grade B‐cell lymphoma.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 553, doi. 10.1002/jha2.436
- By:
- Publication type:
- Article
Linezolid-Induced Pure Red Blood Cell Aplasia.
- Published in:
- Clinical Infectious Diseases, 2002, v. 35, n. 3, p. e29, doi. 10.1086/340982
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Development of a distributed international patient data registry for hairy cell leukemia.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 13, p. 3021, doi. 10.1080/10428194.2022.2109157
- By:
- Publication type:
- Article
Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 3, p. 598, doi. 10.1080/10428194.2020.1837796
- By:
- Publication type:
- Article
Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1636, doi. 10.1080/10428194.2020.1737690
- By:
- Publication type:
- Article
Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1627, doi. 10.1080/10428194.2020.1728748
- By:
- Publication type:
- Article
Multiple B cell malignancies in patients with chronic lymphocytic leukemia: epidemiology, pathology, and clinical implications.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 5, p. 1037, doi. 10.1080/10428194.2019.1709830
- By:
- Publication type:
- Article
Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 3, p. 625, doi. 10.1080/10428194.2017.1347931
- By:
- Publication type:
- Article
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study.
- Published in:
- Leukemia & Lymphoma, 2016, v. 57, n. 7, p. 1585, doi. 10.3109/10428194.2015.1113280
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia and proteomics: protein profiles and links with disease progression still need validation.
- Published in:
- 2016
- By:
- Publication type:
- Opinion